AOTMiT: Transparency Council will evaluate drugs for lymphoma and multidrug-resistant tuberculosis, among others

During the session, it was planned:

1. Preparation of a position paper on the evaluation of the drug Poteligeo (mogamulizumabum) under drug program B.66. "Treatment of patients with T-cell lymphoma (ICD-10: C84)".
2. Preparation of a position paper on the appropriateness of issuing approvals for the reimbursement of the medicinal product Mycobutin (rifabutin) for the indications: multidrug-resistant pulmonary tuberculosis, pulmonary mycobacteriosis, mycobacteriosis of the reproductive tract and generalized atypical mycobacteriosis.
3. Preparation of an opinion on the draft health policy program of the local government unit "Health policy program for medical rehabilitation of residents of the municipality of Czarna Bialostocka for 2024-2028".
4. Preparation of an opinion on the draft health policy program of the local government unit "Program of preventive vaccination against pneumococcal infections for residents of the Municipality of Trzebownisko aged 55 and over for 2024-2026".
5. Preparation of an opinion on the draft health policy program of the local government unit "Program for counteracting the effects of infertility by subsidizing in vitro fertilization treatment for residents of the City of Kwidzyn for 2024-2026".
6. Preparation of an opinion on the draft health policy program of the local government unit "Support for infertility treatment by in vitro fertilization - in vitro for residents of the municipality of Police in the year 2024."

Source: AOTMiT